SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC is trending due to recent U.S. regulatory updates, including NOAA's modernization of deep-sea mining permits, signaling a faster path to commercial recovery for companies like TMC. The community is highly bullish, discussing the potential for a short squeeze amidst high short interest and viewing critical deep-sea minerals as a national security priority. This policy shift is driving significant investor anticipation for expedited permits and a re-evaluation of the sector's long-term value.

Venture Global, Inc. engages in the development and construction of liquefied natural gas production, establishing us as a rapidly growing company delivering critical LNG to the world. It projects include Calcasieu, Plaquemines, CP2, CP3 and Delta projects. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is surging after a pivotal arbitration win against Repsol, which the community views as a major de-risking event and potential precursor for resolving other legal challenges. This positive news, coupled with high short interest, is fueling strong short squeeze speculation and highlighting the company's position as a rapidly expanding LNG exporter amidst robust global demand.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings (RCAT) is trending amid notable institutional accumulation, including a recent BlackRock filing, and an impressive preliminary Q4 revenue outlook signaling robust growth in the defense drone sector. The community is abuzz with anticipation of significant government contract awards and a potential short squeeze, positioning RCAT as a leading player in what many are calling the "Year of the Drone." Investors are closely watching upcoming company presentations and product showcases for further catalysts.

Cipher Mining, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Mining Inc

Cipher Mining Inc. is gaining significant attention as it aggressively expands its AI/HPC data center operations, highlighted by a strategic 200MW site acquisition in Ohio and existing multi-billion dollar contracts with hyperscalers like AWS and Google. The community is actively discussing the company's pivotal shift from pure Bitcoin mining, with many noting strong bullish sentiment and observing robust buying activity on dips, indicative of its growing importance in the critical AI infrastructure sector. Investors anticipate further deal announcements to solidify its position.

Rolls-Royce Holdings Plc designs, develops, manufactures, and services integrated power systems for use in the air, on land, and at sea. The company operates its business through following segments: Civil Aerospace, Power Systems, Defense and New Markets. The Civil Aerospace segment offers commercial aero engines and aftermarket services. The Power Systems segment includes engines, power systems and nuclear systems for civil power generation. The Defense segment consists of military aero engines, naval engines, submarines and aftermarket services. The New Markets segment includes development, manufacture and sales of small modular reactors (SMRs) and new electrical power solutions. The company was founded in March 1906 and is headquartered in London, the United Kingdom.

Rolls-Royce Holdings Plc - ADR

Rolls-Royce Holding PLC (ADR)

Rolls-Royce is experiencing significant bullish momentum, driven by a recently announced interim share buyback program and consistent analyst upgrades. The community is buzzing about the company's burgeoning defense contracts, sustained recovery in civil aerospace, and the transformative potential of its Small Modular Reactor (SMR) technology, especially for powering AI data centers. This strategic positioning across critical global sectors is fueling strong investor confidence ahead of upcoming earnings.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is experiencing intense market conversation ahead of its earnings report, fueled by recent analyst upgrades and growing excitement around its foundry business and government partnerships. Community discussion highlights the potential for substantial gains and a short squeeze, though some express caution about a "sell the news" event after the stock's considerable ascent. This momentum reflects Intel's ongoing efforts to solidify its position in the critical semiconductor and AI industries.

PAVmed, Inc. is a multi-product life sciences company, which engages in the innovation, development, acquisition, and commercialization of products that target unmet medical needs with large addressable market opportunities. Its products include Lucid Diagnostics and Veris Health. The company was founded by Lishan Aklog and Brian J. deGuzman on June 26, 2014 and is headquartered in New York, NY.

PAVmed Inc

PAVmed is currently experiencing a surge in trading activity following news that its subsidiary, Lucid Diagnostics, secured a significant contract with the U.S. Department of Veterans Affairs for its EsoGuard Esophageal DNA Test. This development is fueling widespread discussion, with many in the community anticipating a substantial short squeeze and comparing the potential for explosive gains to past low-float runners, while others express caution regarding potential dilution.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is experiencing a strong rally following positive five-year follow-up data for its personalized cancer vaccine in combination with Merck's Keytruda, validating its mRNA technology for oncology. This, alongside a recent patent victory and high short interest, is driving bullish sentiment and sparking community conversations about the company's long-term potential beyond its pandemic-era success. Investors are actively re-evaluating Moderna as a diversified therapeutics powerhouse.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Chatham, NJ.

Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals is drawing significant attention following a notable investment from Point72 Asset Management, which has spurred bullish sentiment and renewed discussions among investors. The community is actively debating the market potential of its recently launched fibromyalgia treatment, Tonmya, citing positive patient testimonials and upcoming sales trajectory data, alongside anticipation for its Lyme disease prevention pipeline. This optimism is balanced by historical concerns around dilution, making it a highly contested topic in the biotech sector.

WeRide, Inc. operates as an investment holding company. It engages in the sale of autonomous driving vehicles, primarily including robobuses, robotaxis, robosweepers and related sensor suites. The company was founded by Tony Xu Han and Yan Li in February 2017 and is headquartered in Guangzhou, China.

WeRide Inc. - ADR

WeRide is experiencing significant conversation following strong Q3 financial results, showcasing substantial revenue growth and improved margins, alongside securing a pioneering city-level fully driverless robotaxi permit outside the U.S. and launching commercial services with Uber in Abu Dhabi. Community discussion highlights these operational milestones and notable institutional accumulation by ARK Invest, yet sentiment remains divided with some expressing frustration over the stock's valuation in the highly competitive autonomous driving sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of delivering groundbreaking therapies using lipid nanocrystal platform delivery technology to maximize global clinical impact and patient access. The company was founded by Herbert J. Conrad and Jerome D. Jabbour in May 2013 and is headquartered in Bedminster, NJ.

Matinas Biopharma Holdings Inc

Up 10% or more

0% to up 9%

Down 1% to 9%

Down 10% or more

The S&P 500 enters 2026 after a strong run. What kind of return do you expect this year?

How will the S&amp;P 500 perform in 2026?

Current Price	$0.59
Prev Close	$0.6374
Open	$0.64
Dividend Yield	0.00%
50-Day Moving Average	$0.7996
Beta	1.47
Avg. Volume	36,290.00
PE Ratio	-0.17

52-Week High	$3.09
52-Week Low	$0.4748
Market Capitalization	$4.08M
EPS (Annual)	-$4.98
Price to Book	0.54
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

MTNB
Matinas Biopharma Holdings Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MTNB News

MTNBMatinas Biopharma Holdings Inc